Login to Your Account

Astex Deal With Boehringer Worth Up To $45M Per Target

By Nuala Moran

Wednesday, March 17, 2004
LONDON - Astex Technology Ltd. agreed to a multi-target drug discovery deal with Boehringer Ingelheim International GmbH, in which each target could yield up to $45 million in research and development costs and milestones for Astex, up to the point of commercialization. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription